A new survey from Health found that many GLP-1 users still face stigma and judgment, even as the drugs become more common and ...

Rates of overweight and obesity have more than doubled in the United States during the last three decades, according to a new analysis. By 2050, it’s anticipated that 213 million adults (age, > 25 ...

In this article, we exploit the recent, rapid diffusion of the use of GLP-1 drugs among individuals with diabetes to measure the effect of the use of these drugs on mental health, self-rated health, ...

GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women among the most common users. Despite their high use in this group, women ...

The proportion of patients taking a GLP-1 weight-loss drug following bariatric surgery increased substantially in recent years, although the timing of initiation after surgery varied widely, a large ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...

Share on Pinterest An increasing number of people without diabetes are using GLP-1 agonist drugs for weight loss only. Image credit: MarkHatfield/Getty Images. The last few years have seen a marked ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Women who used a GLP-1 before pregnancy were more likely ...